Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
✉ Email this page to a colleague
OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-05-23 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
Jury Demand | None | Referred To | Karen M. Williams |
Patents | 8,017,615; 8,580,796; 8,642,760 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED
Details for OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED (D.N.J. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-05-23 | 1 | of U.S. Patent No. 8,017,615 (“the ’615 patent”), U.S. Patent No. 8,580,796 (“the ’796 patent”), and …and U.S. Patent No. 8,642,760 (“the ’760 patent”), arising under the United States patent laws, Title 35… FIRST COUNT FOR PATENT INFRINGEMENT 14. The U.S. Patent and Trademark Office (“PTO…the ’615 patent is attached as Exhibit A. 15. Otsuka is the owner of the ’615 patent by virtue…the ’796 patent is attached as Exhibit B. 29. Otsuka is the owner of the ’796 patent by virtue | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |